Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Stéphane Baudet"'
Autor:
Raafat Fares, Timothé Flénet, Jonathan Vial, Marine Ravaz, Virginie Roger, Christophe Bory, Stéphane Baudet
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 117:107195
Respiratory and cardiovascular systems are among the vital organ systems that should be studied in safety pharmacology core battery test. Non-invasive jacketed external telemetry technology that enables concomitant monitoring of both systems has been
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 105:106782
Autor:
Valerie Bellingard, Stéphane Baudet, Jean-Paul Briffaux, Mikhail Kalinichev, Catherine George, Dina Anderson
Publikováno v:
Toxicon. 123:S4-S5
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 88:204
Autor:
Estelle Chalencon, Marie Latzko, Kevin Gilbert, Jean-Paul Briffaux, Olivier Boucheix, Stéphane Baudet, Christophe Bory, Philippe Lege
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 88:221
Autor:
Kathrin Beulich, Jutta Weisser, Stéphane Baudet, Juergen Prestle, Burkert Pieske, Ursula Bieligk, Gerd Hasenfuss, Anita P. Janssen, Jacques Noireaud, Paul M.L. Janssen
Publikováno v:
Cardiovascular Research. 50:486-494
Protein kinase C (PKC) is thought to be involved in the regulation of the mammalian cardiac excitation-contraction coupling process by vasoactive peptides like endothelin-1 (ET-1). However, the demonstration of a causal link between activation of spe
Autor:
Stéphane Baudet, Jacques Noireaud
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 42:21-30
Investigations of the coupling between contraction and relaxation (contraction-relaxation [CRC] process) in isometric conditions are essential in determining whether pharmacologic interventions or cardiac diseases specifically modify isometric relaxa
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 75:174-175
Autor:
Stéphane Baudet
Publikováno v:
Cardiovascular Research. 65:299-301
See article by Takahashi et al. (pages 356–365) in this issue . Despite major progress in the pharmacological management of congestive heart failure (CHF), life expectancy of patients suffering from CHF remains low [1]. Progress in the treatment of
Autor:
Stéphane Baudet
Publikováno v:
Cardiovascular Research. 59:529-531
See article by Zolk et al. [11] (pages 563–572) in this issue. Despite several major advances in the management of congestive heart failure such as the introduction of angiotensin-converting enzyme inhibitors and beta-blockers, the prognosis of CHF